Tirzepatide currently being a twin GLP-1 and GIP agonist, it can be prompt the GIP ingredient of dual agonism might be accountable for the extra benefit, given the likely advantage of GIP receptor agonism on peripheral insulin sensitization. Consequently, tirzepatide was more practical than dulaglutide in lessening fasting dietary TAG [6,7].MDPI a